Christian Michael Glibert bought $641k of FEED
owner at NanoVibronix, Inc.. 240,000 shares at an average of $2.67, traded Jan 14, 2026, filed Feb 11, 2026.
Score components
- +12Role10% owner
- +20Trade size$641k at market
- +8Relative to holdingsFirst purchase: no shares before this trade
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
- -5Outside holderA 10% owner who is not an officer or director
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -33.2%, 3m -57.2%, 6m -84.9%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0002111050-26-000002, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jan 14, 2026 | POpen-market purchase Common Stock, par value $0.001 per share | +240,000 | $2.67 | $641k | 240,000 | Feb 11, 2026 |
Related signals
Other insiders at NanoVibronix, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 39Weak | FEEDsell NanoVibronix, Inc. | Christian Michael Glibert other | $144k 210,000 shares | -100% | |
| 12Weak | FEEDsell NanoVibronix, Inc. | Bank Of America Corp /de/ owner | $8,906 2,918 shares | -1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.